RBC Lifts Price Target on Ionis Pharmaceuticals to $100 From $95, Keeps Outperform Rating
Idag, 15:27
Idag, 15:27
09:27 AM EDT, 04/30/2026 (MT Newswires) -- Ionis Pharmaceuticals (IONS) has an average rating of overweight and mean price target of $105.45 according to analysts polled by FactSet.
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
Idag, 15:27
09:27 AM EDT, 04/30/2026 (MT Newswires) -- Ionis Pharmaceuticals (IONS) has an average rating of overweight and mean price target of $105.45 according to analysts polled by FactSet.
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
Analys
Rapporter
Analys
Rapporter
1 DAG %
Senast
OMX Stockholm 30
0,66%
(13:00)
Hacksaw
Idag, 14:30
Hacksaws VD sägs upp
OMX Stockholm 30
1 DAG %
Senast
3 060,48